Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2014; 20(26): 8407-8415
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8407
Nonalcoholic fatty liver disease and cardiovascular disease
Hong Liu, Hong-Yun Lu
Hong Liu, Hong-Yun Lu, Department of Endocrinology and Metabolism, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China
Author contributions: Liu H and Lu HY equally contributed to this paper.
Correspondence to: Dr. Hong-Yun Lu, Department of Endocrinology and Metabolism, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China. luhongyun2013@163.com
Telephone: +86-756-2528741 Fax: +86-756-2528210
Received: October 26, 2013
Revised: January 4, 2014
Accepted: April 8, 2014
Published online: July 14, 2014
Processing time: 260 Days and 19.2 Hours
Abstract

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are two diseases that are common in the general population. To date, many studies have been conducted and demonstrate a direct link between NAFLD and CVD, but the exact mechanisms for this complex relationship are not well established. A systematic search of the PubMed database revealed that several common mechanisms are involved in many of the local and systemic manifestations of NAFLD and lead to an increased cardiovascular risk. The possible mechanisms linking NAFLD and CVD include inflammation, oxidative stress, insulin resistance, ectopic adipose tissue distribution, dyslipidemia, endothelial dysfunction, and adiponectin, among others. The clinical implication is that patients with NAFLD are at an increased risk of CVD and should undergo periodic cardiovascular risk assessment.

Keywords: Nonalcoholic fatty liver disease; Cardiovascular disease; Metabolic syndrome; Risk assessment

Core tip: The link between nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) should be carefully evaluated in future research, which represents an intriguing field of investigation. A better understanding of the role of inflammation, oxidative stress, and insulin resistance, among other mechanisms, may be necessary to clarify the pathogenesis of NAFLD and CVD, and thereby contribute to the development of new therapies.